🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
144,67 USD
Máx. histórico
156,45
70 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-7,53%
Rango 52 semanas
82,01 – 156,92
Variación hoy
-2,49%
Cierre anterior
148,36
Rango de hoy
143,47 – 147,62
Volumen hoy
8.862.415
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,42%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 146,13 (puede no estar actualizado)
- Dividend yield
- 2,29% (puede no estar actualizado)
- Precio objetivo analistas
- 160,29 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2022 | 77,01 | 78,29 | 76,08 | 77,73 | -0,13% | 2,87% | 14.008.400 |
| 04/03/2022 | 76,68 | 77,86 | 76,02 | 77,83 | +0,88% | 2,40% | 12.216.300 |
| 03/03/2022 | 76,77 | 77,54 | 76,41 | 77,15 | +0,63% | 1,47% | 8.191.100 |
| 02/03/2022 | 76,31 | 77,22 | 76,06 | 76,67 | +0,43% | 1,52% | 9.697.500 |
| 01/03/2022 | 76,50 | 77,76 | 75,95 | 76,34 | -0,31% | 2,37% | 9.807.300 |
| 28/02/2022 | 75,83 | 76,76 | 74,78 | 76,58 | +0,34% | 2,61% | 14.126.100 |
| 25/02/2022 | 74,20 | 77,29 | 74,17 | 76,32 | +3,82% | 4,20% | 13.665.900 |
| 24/02/2022 | 75,10 | 75,32 | 72,88 | 73,51 | -3,07% | 3,25% | 21.135.600 |
| 23/02/2022 | 76,19 | 76,44 | 75,62 | 75,84 | -0,14% | 1,08% | 9.659.100 |
| 22/02/2022 | 76,46 | 76,86 | 75,61 | 75,95 | -0,55% | 1,63% | 9.052.500 |
| 18/02/2022 | 76,32 | 76,86 | 75,89 | 76,37 | +0,01% | 1,27% | 8.780.500 |
| 17/02/2022 | 76,85 | 76,93 | 76,00 | 76,36 | -1,11% | 1,21% | 8.889.300 |
| 16/02/2022 | 77,20 | 77,80 | 76,93 | 77,22 | -0,76% | 1,13% | 9.981.300 |
| 15/02/2022 | 77,51 | 78,19 | 77,32 | 77,81 | +1,75% | 1,12% | 11.425.600 |
| 14/02/2022 | 76,63 | 76,70 | 75,11 | 76,47 | -0,22% | 2,07% | 9.881.100 |
| 11/02/2022 | 76,40 | 77,90 | 76,17 | 76,64 | +0,10% | 2,26% | 9.342.300 |
| 10/02/2022 | 76,36 | 76,77 | 75,93 | 76,56 | +0,04% | 1,10% | 12.437.600 |
| 09/02/2022 | 77,17 | 77,33 | 76,41 | 76,53 | -0,49% | 1,19% | 15.183.100 |
| 08/02/2022 | 77,10 | 77,33 | 75,82 | 76,91 | -0,86% | 1,96% | 17.486.500 |
| 07/02/2022 | 78,79 | 78,92 | 77,44 | 77,58 | -1,25% | 1,88% | 23.615.300 |
| 04/02/2022 | 78,51 | 79,55 | 78,20 | 78,56 | -0,57% | 1,72% | 10.716.200 |
| 03/02/2022 | 81,65 | 81,80 | 78,40 | 79,01 | -3,66% | 4,16% | 19.181.400 |
| 02/02/2022 | 81,80 | 82,30 | 81,26 | 82,01 | +0,11% | 1,27% | 13.988.200 |
| 01/02/2022 | 81,96 | 82,12 | 81,08 | 81,92 | +0,54% | 1,27% | 10.803.300 |
| 31/01/2022 | 81,02 | 81,72 | 80,80 | 81,48 | +0,72% | 1,14% | 13.035.000 |
| 28/01/2022 | 79,54 | 80,99 | 79,18 | 80,90 | +0,40% | 2,28% | 13.915.300 |
| 27/01/2022 | 78,42 | 81,60 | 78,42 | 80,58 | +1,82% | 4,06% | 20.187.200 |
| 26/01/2022 | 79,39 | 80,34 | 78,73 | 79,14 | -0,40% | 2,03% | 13.046.600 |
| 25/01/2022 | 78,42 | 79,78 | 77,78 | 79,46 | +0,80% | 2,55% | 13.662.400 |
| 24/01/2022 | 79,77 | 80,11 | 76,65 | 78,83 | -1,44% | 4,34% | 17.289.000 |